Proteasome inhibitors in mantle cell lymphoma
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference65 articles.
1. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants;Majlis;J Clin Oncol,1997
2. Improvement of overall survival in advanced stage mantle cell lymphoma;Herrmann;J Clin Oncol,2009
3. Rituximab and CHOP induction therapy for newly diagnosed mantle–cell lymphoma: molecular complete responses are not predictive of progression-free survival;Howard;J Clin Oncol,2002
4. A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma;Wilder;Clin Lymphoma,2001
5. Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study;Jermann;Ann Oncol,2004
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors;Cell Communication and Signaling;2024-02-08
2. Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies;Pharmaceuticals;2023-01-12
3. Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes;Frontiers in Cellular and Infection Microbiology;2022-07-07
4. A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma;Current Topics in Medicinal Chemistry;2021-05-26
5. Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer;Drug Design, Development and Therapy;2020-10
Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3